Imaging in Clinical Trials Market - Forecast(2019 - 2024)

Report Code: HCR 1296 Report Format: PDF + Excel (Delivery in 48 Hrs)
1. Imaging in Clinical Trials Market - Overview
1.1. Definitions and Scope
2. Imaging in Clinical Trials Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Imaging in Clinical Trials Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Imaging in Clinical Trials Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Imaging in Clinical Trials Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Imaging in Clinical Trials Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Imaging in Clinical Trials Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Imaging in Clinical Trials Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Introduction
8.3.2. Services
8.3.2.1. Operational Imaging Services
8.3.2.2. Read Analysis Services
8.3.2.3. System and Technical Support Services
8.3.2.4. Trial Design Consulting Services
8.3.3. Software
9. Imaging in Clinical Trials Market – By Modality  (Market Size -$Million / $Billion)
9.1. Introduction
9.2. Computed Tomography (CT)
9.3. Positron Emission Tomography (PET)
9.4. Magnetic Resonance Imaging (MRI)
9.5. X-Ray
9.6. Mammography
9.7. Ultrasound
9.8. Single-Photon Emission Computerized Tomography (SPECT)
9.9. Echocardiography
9.10. Others
10. Imaging in Clinical Trials Market – By Therapeutic Area   (Market Size -$Million / $Billion)
10.1. Introduction
10.2. Oncology
10.2.1. Blood Cancer
10.2.2. Breast Cancer
10.2.3. Gastrointestinal Cancer
10.2.4. Prostate Cancer
10.2.5. Skin Cancer
10.2.6. Respiratory/Lung Cancer
10.2.7. Pancreatic Cancer
10.2.8. Thyroid Cancer
10.2.9. Uterine Cancer
10.2.10. Others
11. Imaging in Clinical Trials – By End User (Market Size -$Million / $Billion)
11.1. Segment type Size and Market Share Analysis 
11.2. Application Revenue and Trends by type of Application
11.3. Application Segment Analysis by Type
11.3.1. Introduction
11.3.2. Pharmaceutical Companies
11.3.3. Biotechnology Companies
11.3.4. Medical Device Manufacturers
11.3.5. Government and Academic Institutions
11.3.6. Contract Research Organization (CRO)
11.3.7. Others 
12. Imaging in Clinical Trials - By Geography (Market Size -$Million / $Billion)
12.1. Imaging in Clinical Trials Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3. Imaging in Clinical Trials - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5. Imaging in Clinical Trials - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7. Imaging in Clinical Trials – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13. Imaging in Clinical Trials Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14. Imaging in Clinical Trials Market – Industry / Segment Competition landscape Premium
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15. Imaging in Clinical Trials Market – Key Company List by Country Premium
16. Imaging in Clinical Trials Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. BioClinica, Inc.
16.3. PAREXEL International Corporation
16.4. Intrinsic Imaging, LLC
16.5. WorldCare Clinical, LLC
16.6. ICON plc
16.7. KEOSYS Medical Imaging
16.8. MEDIAN Technologies
16.9. Navitas Life Sciences
16.10. Mint Medical GmbH
16.11. Company 10 
16.12. Company 11 
16.13. Company 12 and More
"*Financials would be provided on a best efforts basis for private companies"
17. Imaging in Clinical Trials Market -Appendix
17.1. Abbreviations
17.2. Sources
18. Imaging in Clinical Trials Market -Methodology Premium
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends